180 likes | 441 Vues
Purpose. Guide program managers in Ministries of Health, UNFPA COs and partner agencies in when developing or updating their cervical cancer prevention and control programs. Who participated. Experts from 14 countriesGAVI AllianceIPPFJhpiegoPAHOPATHUICCWHOUNFPA . Structure. Cervical Canc
 
                
                E N D
1. February 2011 Comprehensive Cervical Cancer Prevention and Control: Program Guidance for Countries 
2. Purpose     Guide program managers in Ministries of Health, UNFPA COs and partner agencies in when developing or updating their cervical cancer prevention and control programs 
3. Who participated Experts from 14 countries
GAVI Alliance
IPPF
Jhpiego
PAHO
PATH
UICC
WHO
UNFPA  
4. Structure Cervical Cancer Prevention and Control Programming
Integration of HPV Vaccine Delivery in Health Systems
Advocacy and Community Mobilization 
5. Guidance for National Strategies and Programming for Cervical Cancer Prevention “In order to have an impact on cervical cancer mortality these programs must have universal coverage of targeted population and financing for long-tem sustainability”  
6. Leadership and Governance National normative framework
Cervical prevention and control should be part of national RH programs
Multi-disciplinary  committee/task force on cervical cancer: coordination role
Leveraging resources through partnership with non-health programs
Focus on all women of the target age especially those in marginalized  groups 
7. Leadership and Governance Allocation of sufficient resources to scale up 
Apply health system approach 
Access to treatment of precancerous lesions
Screening and pre-cancer treatment – part of essential health services
Delivery through PHC services
Universal coverage of services
 
8. Financing Mix of public and private and out-of-pocket fees should cover the costs of prevention services
Subsidy of services to ensure access for disadvantaged groups
Principles of WHO-UNICEF Joint Statement of Vaccine Donation should be applied when accepting donations for CCP 
9. Service Delivery Screening delivered at PHC; integrated in vertical SRH programs  (STIs, oncology, ASRH, etc)
Services should be accessible for disadvantaged women 
Innovative approaches to screening may be tested and utilized 
When starting CCCP cytology-based screening is not advisable (low sensitivity and high health system requirements)  
10. Service Delivery Where cytology-based programs established, assessment should  be done to determine whether to continue strengthening these programs or improve their quality and coverage through introduction of other screening methods
Combination of different screening modalities can be used
Strengthening referral systems
Algorithm for programs to treat women with precancerous lesions should be chosen based on resources and health system infrastructure
 
11. Human Resource Management Geographical distribution and availability of screening tests
Motivation of staff
Attrition of staff over time
Supervision, management and governance
Training for counseling and screening, treatment, lab services and maintenance of equipment
Task sharing and task shifting 
12. Technology and Equipment Proper management of procurement processes, storage and distribution
Financing for procurement should consider costs associated with maintenance  
13. Health Information System HIS should be able to monitor coverage of screening and adequate treatment using WHO indicators
Quality and completeness  of registered data
Operation research 
Avoid a vertical system of data collection only for cervical cancer
 
14. Integration of HPV Vaccine Delivery into Health Systems “The principles highlighted in the WHO  position paper on HPV vaccines recommend introduction of these vaccines when certain conditions are met” 
15. Leadership and Governance  Introduction plan for HPV vaccination – part of comprehensive cervical cancer prevention and control strategy; reflected in cMYP
Vaccination should be coordinated with other health services and information for youth   
16. Financing The bottom line: MOH has to have resources and capacity to sustain the vaccination programs after donor funding is exhausted 
17. Service Delivery Modalities No evidence on which vaccine delivery modality is the most effective
Coverage is important 
Countries should consider whether vaccination should be voluntary or mandatory, and whether it requires written or implied consent 
18. Advocacy and Community Mobilization Advocacy plan: policies required for comprehensive programming, and behavioral changes ;
Evidence-based communication messages for target audiences;
Opportunities to give information to adolescents on HIV/STIs prevention;
Strategic dissemination of information through mass media channels 
Engagement of public figures in advocacy campaigns
Reach out to marginalized populations through civil society organizations